BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38351155)

  • 21. Unusual paediatric spinal myxopapillary ependymomas: Unique molecular entities or pathological variations on a theme?
    Rogers S; Jones DTW; Ireland A; Gottardo NG; Endersby R
    J Clin Neurosci; 2018 Apr; 50():144-148. PubMed ID: 29402569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
    Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
    Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of heterozygosity on chromosome 22 in human ependymomas.
    Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W
    Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
    Ebert C; von Haken M; Meyer-Puttlitz B; Wiestler OD; Reifenberger G; Pietsch T; von Deimling A
    Am J Pathol; 1999 Aug; 155(2):627-32. PubMed ID: 10433955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal growth factor receptor overexpression is common and not correlated to gene copy number in ependymoma.
    Friedrich C; von Bueren AO; Kolevatova L; Bernreuther C; Grob T; Sepulveda-Falla D; van den Boom L; Westphal M; Simon R; Glatzel M
    Childs Nerv Syst; 2016 Feb; 32(2):281-90. PubMed ID: 26686534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of chromosome 1q gain in intracranial ependymomas.
    Rajeshwari M; Sharma MC; Kakkar A; Nambirajan A; Suri V; Sarkar C; Singh M; Saran RK; Gupta RK
    J Neurooncol; 2016 Apr; 127(2):271-8. PubMed ID: 26725097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomas.
    Yang I; Nagasawa DT; Kim W; Spasic M; Trang A; Lu DC; Martin NA
    J Clin Neurosci; 2012 Jun; 19(6):779-85. PubMed ID: 22516549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of pediatric Grade II spinal ependymomas: a population-based study.
    Lin Y; Jea A; Melkonian SC; Lam S
    J Neurosurg Pediatr; 2015 Mar; 15(3):243-9. PubMed ID: 25525932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases.
    Stephen JH; Sievert AJ; Madsen PJ; Judkins AR; Resnick AC; Storm PB; Rushing EJ; Santi M
    J Neurosurg Pediatr; 2012 Jun; 9(6):646-53. PubMed ID: 22656257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Karyotype studies in 18 ependymomas with literature review of 107 cases.
    Mazewski C; Soukup S; Ballard E; Gotwals B; Lampkin B
    Cancer Genet Cytogenet; 1999 Aug; 113(1):1-8. PubMed ID: 10459338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic characterization of ependymomas reveals 6q loss as the most common aberration.
    Olsen TK; Gorunova L; Meling TR; Micci F; Scheie D; Due-Tønnessen B; Heim S; Brandal P
    Oncol Rep; 2014 Aug; 32(2):483-90. PubMed ID: 24939246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of protein 4.1 family members in ependymomas: a study of 84 cases.
    Rajaram V; Gutmann DH; Prasad SK; Mansur DB; Perry A
    Mod Pathol; 2005 Jul; 18(7):991-7. PubMed ID: 15731777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intradural Extramedullary Primary Ependymoma of the Craniocervical Junction Combined with C1 Partial Agenesis: Case Report and Review of the Literature.
    Morselli C; Ruggeri AG; Pichierri A; Marotta N; Anzidei M; Delfini R
    World Neurosurg; 2015 Dec; 84(6):2076.e1-6. PubMed ID: 26210708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biology and management of ependymomas.
    Wu J; Armstrong TS; Gilbert MR
    Neuro Oncol; 2016 Jul; 18(7):902-13. PubMed ID: 27022130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 9p21 and 13q14 dosages in ependymomas. A clinicopathologic study of 101 cases.
    Rajaram V; Leuthardt EC; Singh PK; Ojemann JG; Brat DJ; Prayson RA; Perry A
    Mod Pathol; 2004 Jan; 17(1):9-14. PubMed ID: 14631364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurofibromatosis-2 and spinal cord ependymomas: Report of two cases and review of the literature.
    Aguilera DG; Mazewski C; Schniederjan MJ; Leong T; Boydston W; Macdonald TJ
    Childs Nerv Syst; 2011 May; 27(5):757-64. PubMed ID: 21132433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaplastic extramedullary cervical ependymoma with leptomeningeal metastasis.
    Pomeraniec IJ; Dallapiazza RF; Sumner HM; Lopes MB; Shaffrey CI; Smith JS
    J Clin Neurosci; 2015 Dec; 22(12):1871-6. PubMed ID: 26601808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triad of Intraspinal Meningioma, Schwannoma, and Ependymoma: Report of an Extremely Rare Case.
    Rasheed F; Fatima S; Ahmad Z
    Int J Surg Pathol; 2016 Feb; 24(1):55-8. PubMed ID: 26316051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatal holocord recurrence of a pregnancy-related, low-grade spinal ependymoma: case report and review of an unusual clinical phenomenon.
    Thakar S; Sivaraju L; Ghosal N; Aryan S; Hegde AS
    Spinal Cord Ser Cases; 2020 Oct; 6(1):93. PubMed ID: 33009374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple primary intramedullary ependymomas: a case report and review of the literature.
    Bydon M; Mathios D; Aguayo-Alvarez JJ; Ho C; Gokaslan ZL; Bydon A
    Spine J; 2013 Oct; 13(10):1379-86. PubMed ID: 23988460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.